Guide a student’s first real research
Our students run real studies on public cancer data. Consultants are researchers and faculty who guide that work, mostly by email. You choose how much you take on, and your name goes on any work you help with.
- Mostly by email
- You choose how much
- Your name on work you help with
What consultants do
إيش دورهمPick any of these. None is required.
Check a group’s plan
Give a guest session
Hear the final talks
Answer questions by email
What you get
- Your name on any work you contribute to. Whoever did the work is named, and nobody else.
- A profile on this page, if you’d like one.
- Students who have been taught to write their plan down first and report what they couldn’t test.
How it works
- We keep in touch by email.
- We only match you to work in your area, and ask before we send anything.
- You can step back at any time.
For supervisors
للمشرفينIn week 9 of the Research cohort, each student sends their study proposal to a science consultant and to a supervisor outside Al Basira, for example at KAU. The method is fixed before any result is seen, and the code is tested first. We ask for a read and a reply, nothing more: no marking, and the student carries on while you read.
- Title
Is PHGDH raised in basal-like breast tumours once tumour purity is taken into account?
- The question
In TCGA breast tumours, is PHGDH expression higher in basal-like than in luminal A tumours, and does the difference hold after adjusting for tumour purity?
- Why it matters, and the gap
PHGDH, the first enzyme of serine synthesis, is often cited as raised in basal-like and ER-negative tumours, and put forward as a target. Most of that rests on cell lines and protein staining. Tumour samples differ in how much of them is cancer, and few papers check whether the difference survives that.
- Data
Breast Invasive Carcinoma (TCGA, PanCancer Atlas) from cBioPortal: RNA-seq and PAM50 subtype. Tumour purity from the PanCancer Atlas ABSOLUTE calls. All public, no permission needed.
- Aim and hypothesis
To compare PHGDH expression between basal-like and luminal A tumours, before and after adjusting for purity. I expect it to be higher in basal-like tumours, and the difference to stay clear of zero after the adjustment.
- The method, fixed before running
PHGDH as log2(RSEM + 1). Welch's t-test with Cohen's d, then a linear model of PHGDH on subtype and purity. Positive control: LDHA, known to be higher in basal-like tumours, must show a difference. Negative control: with the subtype labels shuffled, there must be none. Threshold: d of at least 0.5. What would prove me wrong: a purity-adjusted difference whose 95% interval includes zero, or d below 0.5.
- Tested code
An R script written from the method above, every line explained in my own words, and tested on a small made-up dataset with a known difference, which it found. Link attached.
- AI use
An AI assistant drafted the plotting code and the model from my written method. Every prompt and what I changed is in the attached log. No AI for reading the results or writing them up.
- Timeline
Run the analysis in week 10, write it up in week 11, and hand in the finished study in the project month.
- What I'm asking of you
About twenty minutes to read this, and a reply if anything in the method could make the result misleading. I start running it next week either way, and any change you suggest goes in my notes with your name.
Offer your time Or write to contact@researchbasira.com if a student has sent you one.
Our consultants
مستشاريناLoading…
Offer your time
Tell us a little about your work. Aroob or Haneen will reply by email.